Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1961 1
1971 1
1978 1
1992 2
1993 4
1994 2
1995 1
1996 1
1997 2
1998 1
2001 3
2002 2
2003 1
2004 2
2007 1
2008 1
2009 3
2010 2
2011 1
2013 3
2014 13
2015 10
2016 2
2017 3
2018 1
2020 1
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

64 results
Results by year
Filters applied: . Clear all
Page 1
Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA, Reidy A, Mirandola L, Trotter K, Suvorava N, Figueroa A, Konala V, Aulakh A, Littlefield L, Grizzi F, Rahman RL, Jenkins MR, Musgrove B, Radhi S, D'Cunha N, D'Cunha LN, Hermonat PL, Cobos E, Chiriva-Internati M. Figueroa JA, et al. Int Rev Immunol. 2015 Mar;34(2):154-87. doi: 10.3109/08830185.2015.1018419. Int Rev Immunol. 2015. PMID: 25901860 Review.
Tobacco smoking induces metabolic reprogramming of renal cell carcinoma.
Reigle J, Secic D, Biesiada J, Wetzel C, Shamsaei B, Chu J, Zang Y, Zhang X, Talbot NJ, Bischoff ME, Zhang Y, Thakar CV, Gaitonde K, Sidana A, Bui H, Cunningham JT, Zhang Q, Schmidt LS, Linehan WM, Medvedovic M, Plas DR, Figueroa JAL, Meller J, Czyzyk-Krzeska MF. Reigle J, et al. Among authors: figueroa jal. J Clin Invest. 2021 Jan 4;131(1):e140522. doi: 10.1172/JCI140522. J Clin Invest. 2021. PMID: 32970633 Free PMC article.
Galectins in cancer: carcinogenesis, diagnosis and therapy.
Ebrahim AH, Alalawi Z, Mirandola L, Rakhshanda R, Dahlbeck S, Nguyen D, Jenkins M, Grizzi F, Cobos E, Figueroa JA, Chiriva-Internati M. Ebrahim AH, et al. Among authors: figueroa ja. Ann Transl Med. 2014 Sep;2(9):88. doi: 10.3978/j.issn.2305-5839.2014.09.12. Ann Transl Med. 2014. PMID: 25405163 Free PMC article. Review.
Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.
Pena C, Mirandola L, Figueroa JA, Hosiriluck N, Suvorava N, Trotter K, Reidy A, Rakhshanda R, Payne D, Jenkins M, Grizzi F, Littlefield L, Chiriva-Internati M, Cobos E. Pena C, et al. Among authors: figueroa ja. Ann Transl Med. 2014 Sep;2(9):87. doi: 10.3978/j.issn.2305-5839.2014.09.14. Ann Transl Med. 2014. PMID: 25405162 Free PMC article. Review.
Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
Lu C, Figueroa JA, Liu Z, Konala V, Aulakh A, Verma R, Cobos E, Chiriva-Internati M, Gao W. Lu C, et al. Among authors: figueroa ja. Curr Cancer Drug Targets. 2015;15(7):575-92. doi: 10.2174/156800961507150828223554. Curr Cancer Drug Targets. 2015. PMID: 26324128 Review.
Sperm protein 17 is an oncofetal antigen: a lesson from a murine model.
Arnaboldi F, Menon A, Menegola E, Di Renzo F, Mirandola L, Grizzi F, Figueroa JA, Cobos E, Jenkins M, Barajon I, Chiriva-Internati M. Arnaboldi F, et al. Among authors: figueroa ja. Int Rev Immunol. 2014 Oct;33(5):367-74. doi: 10.3109/08830185.2014.911856. Epub 2014 May 8. Int Rev Immunol. 2014. PMID: 24811209 Review.
Anti-galectin-3 therapy: a new chance for multiple myeloma and ovarian cancer?
Mirandola L, Nguyen DD, Rahman RL, Grizzi F, Yuefei Y, Figueroa JA, Jenkins MR, Cobos E, Chiriva-Internati M. Mirandola L, et al. Among authors: figueroa ja. Int Rev Immunol. 2014 Oct;33(5):417-27. doi: 10.3109/08830185.2014.911855. Epub 2014 May 6. Int Rev Immunol. 2014. PMID: 24801755 Review.
Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis.
Colombo M, Mirandola L, Reidy A, Suvorava N, Konala V, Chiaramonte R, Grizzi F, Rahman RL, Jenkins MR, Nugyen DD, Dalhbeck S, Cobos E, Figueroa JA, Chiriva-Internati M. Colombo M, et al. Among authors: figueroa ja. Int Rev Immunol. 2015 Mar;34(2):188-99. doi: 10.3109/08830185.2015.1027629. Int Rev Immunol. 2015. PMID: 25901861 Free article. Review.
64 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page